"Here's a recipe for academic controversy," observes Richard C. Paddock: "First, find dozens of hard-core teenage smokers as young as 14 and study their brains with high-tech scans. Second, feed vervet monkeys liquid nicotine and then kill at least six of them to examine their brains. Third, accept $6 million from tobacco giant Philip Morris to pay for it all.
Scientists in eight Arctic nations prepared "a landmark assessment of oil and gas activity" in the region over six years, including "a clear set of recommendations on how to extract safely what are thought to be up to one quarter of the world's energy reserves." But the United States government blocked the report's release, as it prepares "to sell off exploration licenses for the frozen Chukchi Sea off Alaska, one of the last intact habitats of the polar bear." One of the authors of the report said the U.S. move "could be linked to activities in the Chukchi Sea ...
The case of Pierre Meneton is fueling demands for legal protections for whistleblowers in France. Meneton is a researcher for the National Institute of Health and the National Institute of Health and Medical Research. He is going to court on January 31, 2008, to face charges of defamation. Several industrial salt producers are suing Meneton for a comment he made during an interview in March 2006. "The lobbying of salt producers and agribusiness is very active.
The fifty-year old nuclear reactor at Chalk River in Ontario, Canada, is running again after the Canadian Parliament overruled the president of the Canadian Nuclear Safety Commission.
"The American public deserves to know when someone is trying to persuade them." — U.S. Federal Communications Commissioner Jonathan Adelstein, Thursday, January 17, 2008
Front Groups Beware of Full Frontal Scrutiny
Today, the Center for Media and Democracy and our partners at Consumer Reports WebWatch launched an exciting new project: Full Frontal Scrutiny. The site seeks to shine a light on front groups -- organizations that state a particular agenda, while hiding or obscuring their identity, membership or sponsorship, or all three. Google the term "front groups" and the number one return is CMD's extensive articles on its SourceWatch site.
The pharmaceutical companies Merck and Schering-Plough, which co-market the cholesterol drug Vytorin, "have gone into damage-control mode, taking out newspaper ads." The PR campaign follows the companies' reluctant publication of a study showing that neither of the drugs present in Vytorin "reduced the buildup of fatty plaque in arteries." The study "was
The pharmaceutical industry is using a novel technique to cheer up people who suffer from clinical depression -- only publishing favorable studies about the effects of its antidepressant medications.